Evidence map›Paper›PMID 38109936›Full record

ArticleNature2024

De novo design of high-affinity binders of bioactive helical peptides.

Susana Vázquez Torres, Philip J Y Leung, Preetham Venkatesh, Isaac D Lutz, Fabian Hink, Huu-Hien Huynh, Jessica Becker, Andy Hsien-Wei Yeh, David Juergens, Nathaniel R Bennett and 20 more

Abstract read
In one paragraph

Article in Nature, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 134 papers.

0numbers the graph read from it
0cells of the map it votes in
134citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

134 citing papers in PubMed.

  1. Article
  2. Article
  3. Scalable Production of aPharmaceutics · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. RSC chemical biology · 2026
    Article
  9. Article
  10. Review
  11. Generative AI-drivenAntibody therapeutics · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

74 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Susana Vázquez Torres *Department of Biochemistry, University of Washington, Seattle, WA, USA.
Philip J Y Leung *Department of Biochemistry, University of Washington, Seattle, WA, USA.
Preetham Venkatesh *Department of Biochemistry, University of Washington, Seattle, WA, USA.
Isaac D LutzDepartment of Biochemistry, University of Washington, Seattle, WA, USA.
Fabian HinkDepartment of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0003-3483-2596
Huu-Hien HuynhDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
Jessica BeckerDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
Andy Hsien-Wei YehDepartment of Biochemistry, University of Washington, Seattle, WA, USA.
David JuergensDepartment of Biochemistry, University of Washington, Seattle, WA, USA.ORCID 0000-0001-6425-8391
Nathaniel R BennettDepartment of Biochemistry, University of Washington, Seattle, WA, USA.ORCID 0000-0001-8590-1454
Andrew N HoofnagleDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.ORCID 0000-0002-6449-0243
Eric HuangDepartment of Genome Sciences, University of Washington, Seattle, WA, USA.
Michael J MacCossDepartment of Genome Sciences, University of Washington, Seattle, WA, USA.ORCID 0000-0003-1853-0256
Marc ExpòsitDepartment of Biochemistry, University of Washington, Seattle, WA, USA.
Gyu Rie LeeDepartment of Biochemistry, University of Washington, Seattle, WA, USA.ORCID 0000-0002-9119-5303
Asim K BeraDepartment of Biochemistry, University of Washington, Seattle, WA, USA.ORCID 0000-0001-9473-2912
Alex KangDepartment of Biochemistry, University of Washington, Seattle, WA, USA.
Joshmyn De La CruzDepartment of Biochemistry, University of Washington, Seattle, WA, USA.
Paul M LevineDepartment of Biochemistry, University of Washington, Seattle, WA, USA.
Xinting LiDepartment of Biochemistry, University of Washington, Seattle, WA, USA.
Mila LambDepartment of Biochemistry, University of Washington, Seattle, WA, USA.
Stacey R GerbenDepartment of Biochemistry, University of Washington, Seattle, WA, USA.
Analisa MurrayDepartment of Biochemistry, University of Washington, Seattle, WA, USA.
Piper HeineDepartment of Biochemistry, University of Washington, Seattle, WA, USA.
Elif Nihal KorkmazDepartment of Biochemistry, University of Washington, Seattle, WA, USA.
Jeff NivalaSchool of Computer Science and Engineering, University of Washington, Seattle, WA, USA.ORCID 0000-0002-8210-5417
Lance StewartDepartment of Biochemistry, University of Washington, Seattle, WA, USA.
Joseph L WatsonDepartment of Biochemistry, University of Washington, Seattle, WA, USA. jwatson3@uw.edu.
Joseph M RogersDepartment of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark. joseph.rogers@sund.ku.dk.
David BakerDepartment of Biochemistry, University of Washington, Seattle, WA, USA. dabaker@uw.edu.ORCID 0000-0001-7896-6217

Funding

User Training and OutreachP30GM124165 · NIGMS · CORNELL UNIVERSITY · PI Nozomi Ando, J Christopher Fromme · 2018 to 2026
$34.2M
Project 4: Novel reagent development to enable molecular characterizationU19AG065156 · NIA · UNIVERSITY OF WASHINGTON · PI MONTINE, THOMAS J · 2020 to 2024
$15.9M
Quantifying proteins in plasma do democratize personalized medicine for patients with type 1 diabetesU01DK137097 · NIDDK · UNIVERSITY OF WASHINGTON · PI ANDREW N HOOFNAGLE, Michael MacCoss · 2023 to 2026
$3.4M
Quantifying proteins in plasma to democratize personalized medicine for patients with type 1 diabetesU01DK121289 · NIDDK · UNIVERSITY OF WASHINGTON · PI HOOFNAGLE, ANDREW N · 2019 to 2021
$1.9M
De novo design of a generalizable protein biosensor platform for point-of-care testingR00EB031913 · NIBIB · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI YEH, HSIEN WEI · 2023 to 2025
$747k
De novo design of a generalizable protein biosensor platform for point-of-care testingK99EB031913 · NIBIB · UNIVERSITY OF WASHINGTON · PI YEH, HSIEN WEI · 2022 to 2022
$80k
NIA NIH HHS U19 AG065156NIBIB NIH HHS K99 EB031913NIBIB NIH HHS R00 EB031913NIDDK NIH HHS U01 DK121289NIDDK NIH HHS U01 DK137097NIGMS NIH HHS P30 GM124165
6 · The paper itself

Abstract

Many peptide hormones form an α-helix on binding their receptors

Indexed as

Computer-Aided DesignDeep LearningPeptidesProteinsBiosensing TechniquesDiffusionGlucagonLuminescent MeasurementsMass SpectrometryModels, MolecularParathyroid HormoneProtein Structure, SecondarySubstrate SpecificityGlucagonParathyroid HormonePeptidesProteins

Identifiers

PMID38109936
PMCPMC10849960

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.